
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F3920500004A72C5CDE99D.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="frontcellneuro" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC10070787/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070787/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Frontiers in Cellular Neuroscience" /><meta name="citation_title" content="Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy" /><meta name="citation_author" content="Pabitra Basnyat" /><meta name="citation_author_institution" content="1Department of Neurology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland" /><meta name="citation_author_institution" content="2Department of Neurology, Tampere University Hospital, Tampere, Finland" /><meta name="citation_author" content="Maria Peltola" /><meta name="citation_author_institution" content="3Department of Psychiatry, Tampere University Hospital, Tampere, Finland" /><meta name="citation_author" content="Jani Raitanen" /><meta name="citation_author_institution" content="4Faculty of Social Sciences (Health Sciences), Tampere University, Tampere, Finland" /><meta name="citation_author_institution" content="5UKK Institute for Health Promotion Research, Tampere, Finland" /><meta name="citation_author" content="Suvi Liimatainen" /><meta name="citation_author_institution" content="2Department of Neurology, Tampere University Hospital, Tampere, Finland" /><meta name="citation_author_institution" content="6Administration Centre, Tampere University Hospital, Tampere, Finland" /><meta name="citation_author" content="Sirpa Rainesalo" /><meta name="citation_author_institution" content="7Division of Acute Treatment, Emergency Department, Intensive Care and Anesthesia, Tampere University Hospital, Tampere, Finland" /><meta name="citation_author" content="Marko Pesu" /><meta name="citation_author_institution" content="8Laboratory of Immunoregulation, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland" /><meta name="citation_author_institution" content="9Fimlab Laboratories, Tampere, Finland" /><meta name="citation_author_institution" content="10Gilead Sciences, Vantaa, Finland" /><meta name="citation_author" content="Jukka Peltola" /><meta name="citation_author_institution" content="1Department of Neurology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland" /><meta name="citation_author_institution" content="2Department of Neurology, Tampere University Hospital, Tampere, Finland" /><meta name="citation_publication_date" content="2023" /><meta name="citation_volume" content="17" /><meta name="citation_doi" content="10.3389/fncel.2023.1129907" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC10070787/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC10070787/" /><meta name="citation_pmid" content="37025699" /><meta name="DC.Title" content="Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Frontiers Media SA" /><meta name="DC.Contributor" content="Pabitra Basnyat" /><meta name="DC.Contributor" content="Maria Peltola" /><meta name="DC.Contributor" content="Jani Raitanen" /><meta name="DC.Contributor" content="Suvi Liimatainen" /><meta name="DC.Contributor" content="Sirpa Rainesalo" /><meta name="DC.Contributor" content="Marko Pesu" /><meta name="DC.Contributor" content="Jukka Peltola" /><meta name="DC.Date" content="2023" /><meta name="DC.Identifier" content="10.3389/fncel.2023.1129907" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy" /><meta property="og:type" content="article" /><meta property="og:description" content="Antibodies against glutamic acid decarboxylase (GADA) are present in multiple neurological manifestations, such as stiff-person syndrome, cerebellar ataxia, limbic encephalitis, and epilepsy. Increasing data support the clinical significance of GADA as ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070787/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10070787/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Cell%20Neurosci%22[journal]" class="navlink">Front Cell Neurosci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10070787
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10070787/pdf/fncel-17-1129907.pdf" class="int-view">PDF (1.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10070787/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10070787/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10070787" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ToX0vkpyA0pCDDMD9G51p4hdwMJceCidU6PZU4eHxGN2rfuBcx18T3d774F95mYc">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F&amp;text=Elevated%20IL-6%20plasma%20levels%20are%20associated%20with%20GAD%20antibodies-associated%20autoimmune%20epilepsy" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070787/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37025699/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37025699/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10070787/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Front%20Cell%20Neurosci%22[journal]" class="navlink">Front Cell Neurosci</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC10070787
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-frontcellneuro.gif" alt="Logo of frontcellneuro" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://www.frontiersin.org/journals/cellular-neuroscience" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Front Cell Neurosci.</span> 2023; 17: 1129907. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2023 Mar 21. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3389%2Ffncel.2023.1129907" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3389/fncel.2023.1129907</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC10070787</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37025699">37025699</a></div></div></div><h1 class="content-title">Elevated IL-6 plasma levels are associated with GAD antibodies-associated autoimmune epilepsy</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Basnyat%20P%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514307281312" co-class="co-affbox">Pabitra Basnyat</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
1
,</sup><sup>
2
,</sup><sup>
*
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peltola%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514349338688" co-class="co-affbox">Maria Peltola</a>,<sup>
3
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Raitanen%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514349335952" co-class="co-affbox">Jani Raitanen</a>,<sup>
4
,</sup><sup>
5
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liimatainen%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514306351424" co-class="co-affbox">Suvi Liimatainen</a>,<sup>
2
,</sup><sup>
6
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Rainesalo%20S%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514313828448" co-class="co-affbox">Sirpa Rainesalo</a>,<sup>
7
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pesu%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514313825712" co-class="co-affbox">Marko Pesu</a>,<sup>
8
,</sup><sup>
9
,</sup><sup>
10
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peltola%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140514302579424" co-class="co-affbox">Jukka Peltola</a><sup>
1
,</sup><sup>
2
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140514307281312"><h3 class="no_margin">Pabitra Basnyat</h3><p><sup>1</sup>Department of Neurology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland</p><p><sup>2</sup>Department of Neurology, Tampere University Hospital, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Basnyat%20P%5BAuthor%5D">Pabitra Basnyat</a></div></div><div id="_co_idm140514349338688"><h3 class="no_margin">Maria Peltola</h3><p><sup>3</sup>Department of Psychiatry, Tampere University Hospital, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peltola%20M%5BAuthor%5D">Maria Peltola</a></div></div><div id="_co_idm140514349335952"><h3 class="no_margin">Jani Raitanen</h3><p><sup>4</sup>Faculty of Social Sciences (Health Sciences), Tampere University, Tampere, Finland</p><p><sup>5</sup>UKK Institute for Health Promotion Research, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Raitanen%20J%5BAuthor%5D">Jani Raitanen</a></div></div><div id="_co_idm140514306351424"><h3 class="no_margin">Suvi Liimatainen</h3><p><sup>2</sup>Department of Neurology, Tampere University Hospital, Tampere, Finland</p><p><sup>6</sup>Administration Centre, Tampere University Hospital, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liimatainen%20S%5BAuthor%5D">Suvi Liimatainen</a></div></div><div id="_co_idm140514313828448"><h3 class="no_margin">Sirpa Rainesalo</h3><p><sup>7</sup>Division of Acute Treatment, Emergency Department, Intensive Care and Anesthesia, Tampere University Hospital, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Rainesalo%20S%5BAuthor%5D">Sirpa Rainesalo</a></div></div><div id="_co_idm140514313825712"><h3 class="no_margin">Marko Pesu</h3><p><sup>8</sup>Laboratory of Immunoregulation, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland</p><p><sup>9</sup>Fimlab Laboratories, Tampere, Finland</p><p><sup>10</sup>Gilead Sciences, Vantaa, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pesu%20M%5BAuthor%5D">Marko Pesu</a></div></div><div id="_co_idm140514302579424"><h3 class="no_margin">Jukka Peltola</h3><p><sup>1</sup>Department of Neurology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland</p><p><sup>2</sup>Department of Neurology, Tampere University Hospital, Tampere, Finland</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Peltola%20J%5BAuthor%5D">Jukka Peltola</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140514308079456_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140514308079456_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140514308079456_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140514308079456_ai" style="display:none"><div class="fm-affl" id="aff1"><sup>1</sup>Department of Neurology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland</div><div class="fm-affl" id="aff2"><sup>2</sup>Department of Neurology, Tampere University Hospital, Tampere, Finland</div><div class="fm-affl" id="aff3"><sup>3</sup>Department of Psychiatry, Tampere University Hospital, Tampere, Finland</div><div class="fm-affl" id="aff4"><sup>4</sup>Faculty of Social Sciences (Health Sciences), Tampere University, Tampere, Finland</div><div class="fm-affl" id="aff5"><sup>5</sup>UKK Institute for Health Promotion Research, Tampere, Finland</div><div class="fm-affl" id="aff6"><sup>6</sup>Administration Centre, Tampere University Hospital, Tampere, Finland</div><div class="fm-affl" id="aff7"><sup>7</sup>Division of Acute Treatment, Emergency Department, Intensive Care and Anesthesia, Tampere University Hospital, Tampere, Finland</div><div class="fm-affl" id="aff8"><sup>8</sup>Laboratory of Immunoregulation, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland</div><div class="fm-affl" id="aff9"><sup>9</sup>Fimlab Laboratories, Tampere, Finland</div><div class="fm-affl" id="aff10"><sup>10</sup>Gilead Sciences, Vantaa, Finland</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="fn-a.i.b.o.a">Edited by: Roumen Balabanov, Northwestern Medicine, United States</div><div id="fn-a.i.b.o.b">Reviewed by: Adriana Bermeo-Ovalle, Rush University Medical Center, United States; Merce Falip, Bellvitge University Hospital, Spain; Manuela Paunovic, Erasmus Medical Center, Netherlands</div><div id="c001">*Correspondence: Pabitra Basnyat, <a href="mailto:dev@null" data-email="if.inut@taynsab.artibap" class="oemail">if.inut@taynsab.artibap</a></div><div id="fn004">This article was submitted to Cellular Neuropathology, a section of the journal Frontiers in Cellular Neuroscience</div></div><div class="fm-article-notes hide half_rhythm" id="idm140514308079456_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2022 Dec 22; Accepted 2023 Feb 28.</div></div><div class="permissions half_rhythm hide" id="idm140514308079456_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2023 Basnyat, Peltola, Raitanen, Liimatainen, Rainesalo, Pesu and Peltola.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div><a href="/pmc/articles/PMC10070787/bin/Data_Sheet_1.pdf" data-ga-action="click_feat_suppl">Data_Sheet_1.pdf</a><span style="color:gray"> (887K)</span></div><div class="small guid">GUID: A8D95A20-615A-406A-8974-131177CD6F56</div></div></dd></dl><dl data-length="121" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></dd></dl></div><div id="abstract-a.i.b.v" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.i.b.vtitle">Abstract</h2><!--article-meta--><div><div id="sec-a.i.b.v.a" class="sec sec-first"><h3 id="sec-a.i.b.v.atitle">Background</h3><p class="p p-first-last">Antibodies against glutamic acid decarboxylase (GADA) are present in multiple neurological manifestations, such as stiff-person syndrome, cerebellar ataxia, limbic encephalitis, and epilepsy. Increasing data support the clinical significance of GADA as an autoimmune etiology of epilepsy, however, there is not yet definitive evidence to confirm the pathogenic link between GADA and epilepsy.</p></div><div id="sec-a.i.b.v.b" class="sec"><h3 id="sec-a.i.b.v.btitle">Objective</h3><p class="p p-first-last">Interleukin-6 (IL-6), a pro-convulsive and neurotoxic cytokine, and interleukin-10 (IL-10), an anti-inflammatory and neuroprotective cytokine, are crucial inflammatory mediators in the brain. Increased production of IL-6 and its association with epileptic disease profiles are well established, suggesting the presence of chronic systemic inflammation in epilepsy. Therefore, in this study, we investigated the association of plasma cytokine concentrations of IL-6 and IL-10 and their ratio with GADA in patients with drug-resistant epilepsy.</p></div><div id="sec-a.i.b.v.c" class="sec"><h3 id="sec-a.i.b.v.ctitle">Methods</h3><p class="p p-first-last">Interleukin-6 and IL-10 concentrations were measured by ELISA in plasma, and the IL-6/IL-10 ratio was calculated in a cross-sectional cohort of 247 patients with epilepsy who had their GADA titers measured previously for their clinical significance in epilepsy. Based on GADA titers, patients were grouped as GADA negative (<em>n</em> = 238), GADA low positive (antibody titers &#x0003c; 1,000 RU/mL, <em>n</em> = 5), and GADA high positive (antibody titers &#x02265; 1,000 RU/mL, <em>n</em> = 4).</p></div><div id="sec-a.i.b.v.d" class="sec"><h3 id="sec-a.i.b.v.dtitle">Results</h3><p class="p p-first-last">Median IL-6 concentrations were significantly higher in patients with high GADA positivity [2.86 pg/mL, interquartile range (IQR) = 1.90&#x02013;5.34 pg/mL] than in GADA-negative patients [1.18 pg/mL, interquartile range (IQR) = 0.54&#x02013;2.32 pg/mL; <em>p</em> = 0.039]. Similarly, IL-10 concentrations were also higher in GADA high-positive patients [1.45 pg/mL, interquartile range (IQR) = 0.53&#x02013;14.32 pg/mL] than in GADA-negative patients [0.50 pg/mL, interquartile range (IQR) = 0.24&#x02013;1.00 pg/mL], however, the difference was not statistically significant (<em>p</em> = 0.110). Neither IL-6 nor IL-10 concentrations were different between GADA-negative and GADA low-positive patients (<em>p</em> &#x0003e; 0.05) or between GADA low-positive or GADA high-positive patients (<em>p</em> &#x0003e; 0.05). The IL-6/IL-10 ratio was also similar among all the study groups.</p></div><div id="sec-a.i.b.v.e" class="sec sec-last"><h3 id="sec-a.i.b.v.etitle">Conclusion</h3><p class="p p-first-last">Increased circulatory concentrations of IL-6 are associated with high GADA titers in patients with epilepsy. These data provide additional pathophysiological significance of IL-6 and help to further describe the immune mechanisms involved in the pathogenesis of GADA-associated autoimmune epilepsy.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">epilepsy, autoimmunity, cytokines, GAD antibodies, IL-6, IL-10</span></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">1. Introduction</h2><p class="p p-first">Autoantibodies against glutamic acid decarboxylase (GADA) are present in 80% of patients with autoimmune type 1 diabetes mellitus (T1DM) and are used as diagnostic markers for T1DM (<a href="#B30" rid="B30" class=" bibr popnode">Sigurdsson and Baekkeskov, 1990</a>; <a href="#B31" rid="B31" class=" bibr popnode">Solimena and De Camilli, 1991</a>). These antibodies are directed against secretory vesicles in pancreatic islet cells, resulting in damage to insulin-producing pancreatic cells, and an important mechanism for the development of T1DM. In addition to T1DM, GADA has been detected in patients with multiple neurological manifestations, including stiff-person syndrome (SPS), cerebellar ataxia, limbic encephalitis, and epilepsy (<a href="#B22" rid="B22" class=" bibr popnode">Munoz-Lopetegi et al., 2020</a>). In the brain, GADA is directed against glutamic acid decarboxylase, the enzyme that is important for the formation of the principal inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and therefore impairs GABA synthesis. There are two different isoforms of GAD that are generated from two different genes, GAD65 and GAD67.</p><p>Increasing evidence supports the clinical importance of GADA and other autoantibodies in epilepsy, providing an immunologic basis for the autoimmune etiology of epilepsy (<a href="#B24" rid="B24" class=" bibr popnode">Peltola et al., 2000</a>; <a href="#B26" rid="B26" class=" bibr popnode">Ranua et al., 2004</a>; <a href="#B19" rid="B19" class=" bibr popnode">McKnight et al., 2005</a>; <a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). A high prevalence of GADA is often associated with temporal lobe epilepsy (TLE); therefore, GADA is considered one of the immunological markers of drug-resistant TLE (<a href="#B10" rid="B10" class=" bibr popnode">Falip et al., 2012</a>). Previously, we detected high titers of GADA in epilepsy patients, and almost 90% of them were patients with TLE (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). Moreover, we have shown that early detection of GAD65 antibodies facilitates the effectiveness of immunotherapy in patients with drug-resistant epilepsy (DRE) (<a href="#B17" rid="B17" class=" bibr popnode">M&#x000e4;kel&#x000e4; et al., 2018</a>).</p><p>Cytokines and autoantibodies have a critical role in the pathogenesis of several autoimmune diseases (<a href="#B21" rid="B21" class=" bibr popnode">Moudgil and Choubey, 2011</a>). In drug-resistant focal epilepsy, especially in TLE, the association of proinflammatory cytokines, particularly interleukin-6 (IL-6), with epileptic disease profiles has been well established (<a href="#B13" rid="B13" class=" bibr popnode">Liimatainen et al., 2013</a>). IL-6 is a pro-convulsive and neurotoxic cytokine that stimulates the production of most acute phase proteins. A variety of immune cells produce IL-6, but the most important ones are macrophages and monocytes at sites of inflammation. In our previous studies, we detected chronically increased serum concentrations of IL-6 in TLE patients compared with those in healthy controls (<a href="#B12" rid="B12" class=" bibr popnode">Liimatainen et al., 2009</a>); these patients also exhibited a postictal increase in plasma IL-6 (<a href="#B2" rid="B2" class=" bibr popnode">Alapirtti et al., 2009</a>). Furthermore, we also observed increased plasma IL-6 in TLE patients compared to extratemporal lobe epilepsy (XLE) patients, suggesting that the epilepsy type is important for determining seizure-induced IL-6 production (<a href="#B1" rid="B1" class=" bibr popnode">Alapirtti et al., 2018</a>), and recently, we observed that IL-6 plasma levels are modified by hippocampal sclerosis (HS) and its lateralization in drug-resistant temporal lobe epilepsy (accepted). Interleukin-10 (IL-10), an anti-inflammatory and neuroprotective cytokine, has been associated with the immunopathology of several diseases, but its role in epilepsy is less studied (<a href="#B5" rid="B5" class=" bibr popnode">Basnyat et al., 2020</a>). In the brain, it inhibits the production of proinflammatory cytokines by microglia, promotes the production of transforming growth factor-&#x003b2; by astrocytes, promotes neuronal cell survival and regulates adult neurogenesis (<a href="#B16" rid="B16" class=" bibr popnode">Lobo-Silva et al., 2016</a>).</p><p class="p p-last">The purpose of this study was to analyses the IL-6 and IL-10 concentrations, including the IL6/IL10 ratio, with regard to GADA titers in the same patient cohort that was previously evaluated for the clinical significance of GAD antibodies in epilepsy (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>).</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">2. Materials and methods</h2><div id="S2.SS1" class="sec sec-first"><h3 id="S2.SS1title">2.1. Patients</h3><p class="p p-first-last">This cross-sectional study comprises 253 consecutive adult patients with drug-resistant epilepsy treated at the Outpatient Clinic of Neurology of Tampere University Hospital. The Ethics Committee approved the study protocol of Tampere University Hospital, and all the patients provided written informed consent according to the Declaration of Helsinki. Epilepsy was classified according to the International League Against Epilepsy (ILAE) guidelines (<a href="#B28" rid="B28" class=" bibr popnode">Scheffer et al., 2017</a>). Epilepsy types were categorized into TLE, frontal lobe, parietal lobe, occipital lobe, multifocal, and unknown focal epilepsies, and idiopathic generalized epilepsy (IGE). Patients with TLE were further assigned to either the TLE with HS group or the TLE without HS group, depending on the presence of HS. DRE was defined as persistent seizures after administering two different anti-seizure medications (ASMs) with adequate dosing (<a href="#B11" rid="B11" class=" bibr popnode">Kwan et al., 2010</a>). Patients with DRE in our study population were evaluated for the possibility of epilepsy surgery. Patients with dementia, moderate or severe intellectual disability or malignant brain tumors were excluded from the study. Data regarding concomitant autoimmune diseases were collected. Due to limited access and practical difficulties in obtaining a meaningful healthy control group, the study lacks cytokines measurement in the healthy population. Therefore, we were unable to compare the cytokines levels between epilepsy patients and healthy control group.</p></div><div id="S2.SS2" class="sec"><h3 id="S2.SS2title">2.2. Detection of GADA</h3><p class="p p-first-last">Glutamic acid decarboxylase in sera was analyzed by radioimmunoassay (RIA) as previously described (<a href="#B27" rid="B27" class=" bibr popnode">Savola et al., 1998</a>) in the Scientific Laboratory, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. When the cut-off limit for high GADA titers was defined based on patients with positive GADA levels, two distinct patient groups were identified: the first with high titers (&#x02265;1,000 RU/ml) and the second with low titers (&#x0003c;1,000 RU/ml) without associated autoimmune diseases. The cut-off limit for GADA positivity was 5.36 RU/ml as described previously (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). The positive findings were validated by immunohistochemistry and immunoblotting of recombinant human GAD65. A detailed explanation related to the calculation of the cut-off limit for GADA positivity was provided previously (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>).</p></div><div id="S2.SS3" class="sec"><h3 id="S2.SS3title">2.3. IL-6 and IL-10 measurements</h3><p class="p p-first-last">Blood samples were collected during scheduled outpatient visits. Blood was collected in a vacutainer EDTA vacuum tube and centrifuged at 3,000 rpm for 10 min, and the separated plasma samples were frozen and stored at &#x02212;70&#x000b0;C until use. Plasma IL-6 and IL-10 concentrations were measured using commercially available enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer&#x02019;s protocol (Pelikine<sup>&#x000ae;</sup> Compact, Sanquin, Amsterdam, Netherlands).</p></div><div id="S2.SS4" class="sec sec-last"><h3 id="S2.SS4title">2.4. Statistical analysis</h3><p class="p p-first-last">Clinical characteristics of the patients were presented as the means and standard deviations (SD) or frequencies and percentages. Continuous variable data were analyzed using the non-parametric Kruskal-Wallis H test or Mann&#x02013;Whitney U test. When examining an association between groups and categorized variables, Pearson&#x02019;s chi-squared test, if assumptions were valid, or Fisher&#x02019;s exact test was used. Spearman&#x02019;s correlation coefficient was used to analyse the correlation between the cytokines and their ratio with the frequency of seizures last month before the lab. The distribution of IL-6 levels, IL-10 levels, and IL-6/IL-10 ratio was visualized using scattergrams. All statistical analyses were performed using Stata statistical software version 17.0 (StataCorp, College Station, TX, USA). The <em>p</em>-values were considered significant at <em>p</em> &#x02264; 0.05. Figures were prepared using GraphPad Prism 5.02 software (GraphPad Software Inc., La Jolla, CA, USA).</p></div></div><div id="S3" class="tsec sec"><h2 class="head no_bottom_margin" id="S3title">3. Results</h2><div id="S3.SS1" class="sec sec-first"><h3 id="S3.SS1title">3.1. Patients</h3><p class="p p-first">A total of 253 epilepsy patients (135 females and 118 males) with a median age of 39.0 years (range: 16&#x02013;76) were enrolled in this study. The clinical characteristics were described in more detail in our previous publications (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>; <a href="#B5" rid="B5" class=" bibr popnode">Basnyat et al., 2020</a>). Six patients had missing IL-6 and IL-10 measurement, therefore only 247 patients who had both GADA and cytokine measurements were included in the analyses. Groups based on GADA titers included a first GADA-negative or normal group, a second GADA low-positive group (antibody titers &#x0003c; 1,000 RU/mL, <em>n</em> = 5), and a third GADA high-positive group (antibody titers &#x02265; 1,000 RU/mL, <em>n</em> = 4, <a href="/pmc/articles/PMC10070787/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). The number of autoimmune diseases in the GADA high-positive group was higher than that in the GADA-negative group (57.1% vs. 7.6%, <em>p</em> = 0.030). The classification of patients based on GADA levels and their clinical characteristics is presented in <a href="/pmc/articles/PMC10070787/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. A summary of previous GADA findings updated with current cytokine findings are presented in <a href="/pmc/articles/PMC10070787/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T1"><h3>TABLE 1</h3><!--caption a7--><div class="caption"><p>Background characteristics, i.e., mean and standard deviation for age, age at diagnosis, and duration of epilepsy or frequency and percentage for other variables.</p></div><div class="xtable"><table frame="box" rules="all" cellspacing="5" cellpadding="5" class="rendered small default_table"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"></td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">GADA-negative</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">GADA low-positive</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">GADA high-positive</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1"><em>P</em>-value</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">N<sup>*</sup></td><td valign="top" align="center" rowspan="1" colspan="1">238</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">125 (52.5)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (62.5)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (71.4)</td><td valign="top" align="center" rowspan="1" colspan="1">0.61<sup>1</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age, years</td><td valign="top" align="center" rowspan="1" colspan="1">38.5 (14.3)</td><td valign="top" align="center" rowspan="1" colspan="1">42.8 (15.9)</td><td valign="top" align="center" rowspan="1" colspan="1">49.6 (16.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.16<sup>2</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Age at onset, years</td><td valign="top" align="center" rowspan="1" colspan="1">16.4 (13.1)</td><td valign="top" align="center" rowspan="1" colspan="1">23.4 (14.7)</td><td valign="top" align="center" rowspan="1" colspan="1">17.3 (11.0)</td><td valign="top" align="center" rowspan="1" colspan="1">0.20<sup>2</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Type of epilepsy</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="top" align="center" rowspan="1" colspan="1">0.15<sup>1</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;TLE</td><td valign="top" align="center" rowspan="1" colspan="1">123 (51.7)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (25.0)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (85.7)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other focal</td><td valign="top" align="center" rowspan="1" colspan="1">83 (34.9)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (62.5)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;IGE</td><td valign="top" align="center" rowspan="1" colspan="1">32 (13.4)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (14.3)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Etiology</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="top" align="center" rowspan="1" colspan="1">0.89<sup>1</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Structural</td><td valign="top" align="center" rowspan="1" colspan="1">136 (57.1)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (62.5)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (42.9)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">72 (30.3)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (25.0)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (42.9)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Genetic</td><td valign="top" align="center" rowspan="1" colspan="1">30 (12.6)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (12.5)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (14.3)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Duration of epilepsy, years</td><td valign="top" align="center" rowspan="1" colspan="1">22.2 (14.6)</td><td valign="top" align="center" rowspan="1" colspan="1">19.5 (18.0)</td><td valign="top" align="center" rowspan="1" colspan="1">32.1 (26.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0.60<sup>2</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">At least one seizure 1 year before lab</td><td valign="top" align="center" rowspan="1" colspan="1">194 (81.9)</td><td valign="top" align="center" rowspan="1" colspan="1">7 (87.5)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (85.7)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00<sup>1</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Autoimmune diseases</td><td valign="top" align="center" rowspan="1" colspan="1">18 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">4 (57.1)</td><td valign="top" align="center" rowspan="1" colspan="1">
<strong>0.002</strong>
<sup>
1
</sup>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Surgery</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<sup>1</sup></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;No surgery</td><td valign="top" align="center" rowspan="1" colspan="1">199 (83.6)</td><td valign="top" align="center" rowspan="1" colspan="1">8 (100.0)</td><td valign="top" align="center" rowspan="1" colspan="1">6 (85.7)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Epilepsy surgery</td><td valign="top" align="center" rowspan="1" colspan="1">18 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1 (14.3)</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x02003;Other lesional surgery</td><td valign="top" align="center" rowspan="1" colspan="1">21 (8.8)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">MRI is abnormal</td><td valign="top" align="center" rowspan="1" colspan="1">121 (55.0)</td><td valign="top" align="center" rowspan="1" colspan="1">5 (62.5)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (42.9)</td><td valign="top" align="center" rowspan="1" colspan="1">0.78<sup>1</sup></td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140514306424624"><a target="object" rel="noopener" href="/pmc/articles/PMC10070787/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t1fn1"><p class="p p-first-last"><sup>1</sup> Fisher&#x02019;s exact test; <sup>2</sup> Kruskal&#x02013;Wallis H test.</p></div><div id="t1fns1"><p class="p p-first-last">IGE, idiopathic generalized epilepsy; TLE, temporal lobe epilepsy; *Six patients had missing cytokine measurement, therefore they are not included in the table. Bold values represent significant <em>P</em>-values.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="T2"><h3>TABLE 2</h3><!--caption a7--><div class="caption"><p>Clinical characteristics and median cytokine levels of GADA positive patients.</p></div><div class="xtable"><table frame="box" rules="all" cellspacing="5" cellpadding="5" class="rendered small default_table"><thead><tr><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Patient number</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Sex</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Age</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Epilepsy type</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Etiology of epilepsy</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Autoimmune diseases</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">GADA S-RIA (RU/ml)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">IS of GADA</td><td valign="top" align="left" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">Other autoantibodies</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">IL-6 (pg/mL)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">IL-10 (pg/mL)</td><td valign="top" align="center" style="color:#ffffff;background-color: #7f8080;" rowspan="1" colspan="1">IL-6/IL-10 ratio</td></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">Thyroiditis, psoriasis</td><td valign="top" align="center" rowspan="1" colspan="1">38,138</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">TPO, TYGL, IgM GM1, LANG</td><td valign="top" align="center" rowspan="1" colspan="1">1.66</td><td valign="top" align="center" rowspan="1" colspan="1">1.15</td><td valign="top" align="center" rowspan="1" colspan="1">1.44</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">HS</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">8,534</td><td valign="top" align="center" rowspan="1" colspan="1">Not done</td><td valign="top" align="left" rowspan="1" colspan="1">TPO, IgG GM1, LANG</td><td valign="top" align="center" rowspan="1" colspan="1">2.63</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td><td valign="top" align="center" rowspan="1" colspan="1">7.85</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">CD, IgA deficiency, juvRA</td><td valign="top" align="center" rowspan="1" colspan="1">4,569</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">ANA, IgG GM1</td><td valign="top" align="center" rowspan="1" colspan="1">6.10</td><td valign="top" align="center" rowspan="1" colspan="1">18.51</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">45</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">Immune</td><td valign="top" align="left" rowspan="1" colspan="1">T1D, demyelinating disease</td><td valign="top" align="center" rowspan="1" colspan="1">1,680</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">TPO, &#x003b2;2GP1, IgM GM1, IgG GM1</td><td valign="top" align="center" rowspan="1" colspan="1">3.09</td><td valign="top" align="center" rowspan="1" colspan="1">1.76</td><td valign="top" align="center" rowspan="1" colspan="1">1.76</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">58</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">HS</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">800</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">AGPC, IgM GM1</td><td valign="top" align="center" rowspan="1" colspan="1">1.69</td><td valign="top" align="center" rowspan="1" colspan="1">1.97</td><td valign="top" align="center" rowspan="1" colspan="1">0.86</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="left" rowspan="1" colspan="1">FLE</td><td valign="top" align="left" rowspan="1" colspan="1">Trauma</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">14.1</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No antibodies</td><td valign="top" align="center" rowspan="1" colspan="1">0.32</td><td valign="top" align="center" rowspan="1" colspan="1">0.21</td><td valign="top" align="center" rowspan="1" colspan="1">1.54</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">40</td><td valign="top" align="left" rowspan="1" colspan="1">TLE</td><td valign="top" align="left" rowspan="1" colspan="1">HS</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">10.9</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No antibodies</td><td valign="top" align="center" rowspan="1" colspan="1">0.27</td><td valign="top" align="center" rowspan="1" colspan="1">0.53</td><td valign="top" align="center" rowspan="1" colspan="1">0.52</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">37</td><td valign="top" align="left" rowspan="1" colspan="1">FLE</td><td valign="top" align="left" rowspan="1" colspan="1">Trauma</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">6.4</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No antibodies</td><td valign="top" align="center" rowspan="1" colspan="1">0.46</td><td valign="top" align="center" rowspan="1" colspan="1">0.33</td><td valign="top" align="center" rowspan="1" colspan="1">1.39</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">48</td><td valign="top" align="left" rowspan="1" colspan="1">FLE</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">6.3</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">IgG GM1</td><td valign="top" align="center" rowspan="1" colspan="1">1.76</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140514311508944"><a target="object" rel="noopener" href="/pmc/articles/PMC10070787/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="fn-a.j.c.b.d.d.a"><p class="p p-first-last">F, female; M, male; TLE, temporal lobe epilepsy; uncl. IGE, unclassified idiopathic generalized epilepsy; FLE, frontal lobe epilepsy; HS, hippocampal sclerosis; CD, celiac disease; IgA, immunoglobulin A; juvRA, juvenile rheumatoid arthritis; T1D, type 1 diabetes; S, serum; IS, intrathecal synthesis; RIA, radioimmunoassay; TPO, thyroperoxidase antibody; GM1, GM1 antibody; LANG, Langerhans cell antibody; TYGL, thyroglobulin antibody; ANA, antinuclear antibody; b2GP1, b2-glycoprotein 1 antibody; AGPC, antigastric parietal cell antibody. Updated and modified from our previous publication (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). IL-6 and IL-10 levels and their ratio are presented as median values in the table.</p></div></div></div></div><div id="S3.SS2" class="sec sec-last"><h3 id="S3.SS2title">3.2. Plasma IL-6 and IL-10 concentrations and their ratio</h3><p class="p p-first">Median IL-6 levels were significantly higher in the high GADA positive group than in GADA-negative group (<em>p</em> = 0.039, <a href="/pmc/articles/PMC10070787/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1A</span></a>). Similarly, IL-10 levels were also higher in the GADA high-positive group than in the GADA-negative group, however, the difference was not statistically significant (<em>p</em> = 0.110, <a href="/pmc/articles/PMC10070787/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>). The difference in the IL-6/IL-10 ratio between these two groups was similar (<a href="/pmc/articles/PMC10070787/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1C</span></a>). The median (IQR) IL-6 levels for the GADA-negative vs. GADA high-positive groups were 1.18 (0.54&#x02013;2.32) vs. 2.86 (1.90&#x02013;5.34), and the median (IQR) IL-10 levels were 0.50 (0.24&#x02013;1.00) vs. 1.45 (0.53&#x02013;14.32). IL-6 and IL-10 levels and their ratio did not change either between GADA-negative and GADA low-positive groups or between the GADA low-positive and GADA high-positive groups (<em>p</em> &#x0003e; 0.05). The distribution of IL-6 and IL-10 levels and their ratio in each group are shown in <a href="/pmc/articles/PMC10070787/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figures 1A&#x02013;C</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC10070787/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140514311379696"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10070787_fncel-17-1129907-g001.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fncel-17-1129907-g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC10070787/bin/fncel-17-1129907-g001.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140514311379696"><a target="object" rel="noopener" href="/pmc/articles/PMC10070787/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC10070787/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">FIGURE 1</a></div><!--caption a7--><div class="caption"><p>Distribution and median concentrations of IL-6 and IL-10 levels and their ratio in different study groups: <strong>(A)</strong> IL-6 levels, <strong>(B)</strong> IL-10 levels, and <strong>(C)</strong> the IL-6/IL-10 ratio.</p></div></div></div><p>Moreover, we made subgroups of patients based on their types of epilepsy, etiologies, and abnormal MRI, and compared the IL-6 and IL-10 levels and their ratio, in different GADA groups. The results showed no significant difference between the groups based on epilepsy types (<em>p</em> &#x0003e; 0.05, <a href="#DS1" rid="DS1" class=" supplementary-material">Supplementary Figures 1A&#x02013;C</a>), between the groups based on etiologies (<em>p</em> &#x0003e; 0.05, <a href="#DS1" rid="DS1" class=" supplementary-material">Supplementary Figures 2A&#x02013;C</a>), and between the groups based on abnormal MRI (<em>p</em> &#x0003e; 0.05, <a href="#DS1" rid="DS1" class=" supplementary-material">Supplementary Figure 3A&#x02013;C</a>). Similarly, we found no significant difference in IL-6 and IL-10 levels and their ratio in subgroups of patients based on with or without autoimmune diseases (<em>p</em> &#x0003e; 0.05, <a href="#DS1" rid="DS1" class=" supplementary-material">Supplementary Figures 4A&#x02013;C</a>).</p><p class="p p-last">We also performed the correlation analysis between the IL-6 and IL-10 levels and their ratio with the seizure frequency during the last month before the lab and the results showed no significant association between the cytokines and their ratio with the seizure frequency in all GADA groups (<a href="#DS1" rid="DS1" class=" supplementary-material">Supplementary Figures 5A&#x02013;I</a>).</p></div></div><div id="S4" class="tsec sec"><h2 class="head no_bottom_margin" id="S4title">4. Discussion</h2><p class="p p-first">The present study assessed the relationship between levels of the soluble cytokines IL-6 and IL-10, including the IL6/IL10 ratio and GADA titers, in patients with DRE in the same population that had GADA titers measured previously to evaluate their clinical significance in epilepsy (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). The results from our present study showed elevated levels of IL-6 in patients who were highly positive for GADA compared to patients who were GADA negative. Moreover, IL-10 levels were also higher in GADA high-positive patients than in GADA-negative patients but lacked a statistically significant difference. The IL-6/IL-10 ratio remained unaltered among all groups.</p><p>Considering the critical role of IL-6-mediated inflammation in autoimmune neurological diseases, increased IL-6 levels in the GADA high-positive group may indicate a role for IL-6 in initiating, and propagating autoimmune inflammation in our patients (<a href="#B21" rid="B21" class=" bibr popnode">Moudgil and Choubey, 2011</a>). Moreover, unchanged levels of IL-10 among GADA groups suggest that IL-10 could not contribute adequate anti-inflammatory supply to counteract the excessive inflammation driven by IL-6. In line with this observation, we recently detected a significant reduction in IL-10 in TLE with HS (<a href="#B5" rid="B5" class=" bibr popnode">Basnyat et al., 2020</a>). Similarly, the altered levels of IL-6 and IL-10 in different GADA groups also indicate a Th1/Th2 cytokine imbalance, a representative phenomenon observed in patients with T1DM (<a href="#B23" rid="B23" class=" bibr popnode">Ng et al., 1999</a>).</p><p>Although comparing the immunopathogenesis of T1DM is irrelevant to epilepsy, an increased risk of epilepsy has been reported in patients with autoimmune diabetes (<a href="#B9" rid="B9" class=" bibr popnode">Dafoulas et al., 2017</a>; <a href="#B35" rid="B35" class=" bibr popnode">Yan et al., 2017</a>). A similar positive association has been previously reported between systemic inflammation, i.e., increased serum cytokine IL-1 &#x003b2;, IL-3, INF- &#x003b3;, and GADA levels in patients with both types of diabetes (<a href="#B4" rid="B4" class=" bibr popnode">Amin et al., 2020</a>) and significantly higher IL-6 and IL-15 concentrations in autoimmune diabetes (<a href="#B29" rid="B29" class=" bibr popnode">Siewko et al., 2019</a>). Thus, the predominance of the GAD-specific antibody response along with systemic inflammation suggest that IL-6 signaling could be a novel pharmacological target in the treatment of GADA-induced autoimmune epilepsy. Several drugs, such as anakinra (human recombinant IL-1Ra), tocilizumab (a monoclonal antibody against the IL-6 receptor) and reparixin (an IL-8 receptor inhibitor), have been suggested as possible drugs to prevent epilepsy (<a href="#B33" rid="B33" class=" bibr popnode">Vezzani et al., 2019</a>). Nonetheless, dual biological components, high GADA titers and elevated systemic levels of IL-6, should be evaluated further for their biomarker potential for the assessment of GADA-induced autoimmune epilepsy and as one of the possible anti-inflammatory interventions in its treatment. We previously reported the significance of early detection of GAD65 antibodies in the immunotherapy treatment of patients with DRE (<a href="#B17" rid="B17" class=" bibr popnode">M&#x000e4;kel&#x000e4; et al., 2018</a>).</p><p>Interleukin-6 not only induces acute phase reactions but also induces autoantibody production, such as anti-aquaporin 4 autoantibody production in neuromyelitis optica (<a href="#B8" rid="B8" class=" bibr popnode">Chihara et al., 2011</a>). In this regard, the ability of IL-6 to induce B-cell differentiation could result in the secretion of several pathological autoantibodies, probably including GADA. Additionally, IL-6 affects T cells by enhancing overreactive Th1 activity, the mechanism responsible for the induction of several organ-specific autoimmune inflammatory diseases, such as multiple sclerosis, rheumatoid arthritis and T1DM (<a href="#B21" rid="B21" class=" bibr popnode">Moudgil and Choubey, 2011</a>). Likewise, excessive and continuous production of IL-6 during epileptic seizures could be the cause of GADA production. Previously, we found that approximately 90% of patients who had high GADA titers also had TLE, and the immunologic profile of these patients suggested a possible autoimmune etiology (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>). An experimental study reported CNS destruction with lethal encephalomyelitis-like disease mediated by GAD-specific CD4<sup>+</sup> T cells; conversely, the effect of B-cell-generated high titer anti-GAD65 autoantibodies had no effect on the incidence or severity of disease (<a href="#B7" rid="B7" class=" bibr popnode">Burton et al., 2010</a>). In addition, GADA high-positive epilepsy patients in our study also had a higher number of other autoimmune diseases than patients without GADA. Furthermore, the number of other autoantibodies was also higher in GADA high-positive patients, as reported previously (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>), which may signify the existence of a poly autoimmune etiology of epilepsy. Along these lines, our findings support the idea that IL-6-mediated systemic inflammation could also be the cause for the presence of high titers of GADA.</p><p>On the other hand, IL-6-mediated systemic inflammation could also be the result of the presence of GADA. The pathogenic significance of GADA in neuroinflammation is complex (<a href="#B18" rid="B18" class=" bibr popnode">McKeon et al., 2012</a>; <a href="#B32" rid="B32" class=" bibr popnode">Toledano et al., 2014</a>). Epilepsy-specific antibodies such as NMDA receptor (NMDAR) and voltage-gated potassium channel (VGKC) complex antibodies are regarded as directly pathogenic to the brain (<a href="#B14" rid="B14" class=" bibr popnode">Liimatainen et al., 2014</a>). Previously, in patients with high GADA titers, we found intrathecal synthesis of GADA, suggesting that GADA could be a marker of an ongoing immune response (<a href="#B15" rid="B15" class=" bibr popnode">Liimatainen et al., 2010</a>), and in the same patients, we found high levels of IL-6. Thus, this finding may support the role of GADA in the pathogenesis of epilepsy, and elevated IL-6 levels in the same patients could reveal a further immunological basis.</p><p>Some studies have suggested that GADA is not pathogenically active by itself but only an indicator of the immunopathological process (<a href="#B6" rid="B6" class=" bibr popnode">Bien and Scheffer, 2011</a>), whereas other findings have supported its pathogenicity (<a href="#B25" rid="B25" class=" bibr popnode">Petroff et al., 1996</a>; <a href="#B20" rid="B20" class=" bibr popnode">Mitoma et al., 2000</a>; <a href="#B34" rid="B34" class=" bibr popnode">Vianello et al., 2008</a>; <a href="#B22" rid="B22" class=" bibr popnode">Munoz-Lopetegi et al., 2020</a>). GAD autoimmunity could induce epileptogenic activity and increases seizure susceptibility thus initiating the activation of inflammatory pathways, both in the periphery and in the CNS, resulting in the higher production of proinflammatory cytokines such as IL-6 (<a href="#B20" rid="B20" class=" bibr popnode">Mitoma et al., 2000</a>). Therefore, these explanations may fairly support that IL-6-mediated systemic inflammation could be the consequence of high GADA titers. It is also important to consider that IL-6 production is triggered by acute epileptic seizures (<a href="#B1" rid="B1" class=" bibr popnode">Alapirtti et al., 2018</a>), increasing the likelihood that they may be causal rather than the consequence of autoimmune aspects of epilepsy.</p><p>Moreover, high titers of peripheral GADA upon systemic inflammation, but not low titers, can cross the blood-brain barrier mediating CNS damage, as in the case of SPS, and should be evaluated in epilepsy as well (<a href="#B3" rid="B3" class=" bibr popnode">Ali et al., 2011</a>). Therefore, high IL-6 production and high GADA titers could be the dual components attributable to the genesis of autoimmune epilepsy. Moreover, since we lack a broader interpretation of our second hypothesis, a future study is warranted with a simultaneous measurement of IL-6 and GADA in a new set of patients.</p><p>One of the main limitations of our study is the low number of patients and the retrospective nature of the study design, which makes it difficult to draw definite conclusions. However, GADA-associated epilepsy is a rare entity, and a larger sample size is implausible. In addition, due to limited access, we were unable to perform cytokine measurements in the CSF samples.</p><p class="p p-last">Taken together, the results of the present study may provide additional pathophysiologic significance of IL-6 in GADA-associated autoimmune epilepsy. It also offers the new possibility that IL-6 signaling could be a promising anti-inflammatory therapeutic intervention in the treatment of GADA-induced autoimmune epilepsy. However, future research is warranted to elucidate whether GADA are pathogenic entities or only serve as surrogate markers for autoimmune diseases mediated by cytotoxic T cells.</p></div><div id="S5" class="tsec sec"><h2 class="head no_bottom_margin" id="S5title">Data availability statement</h2><p class="p p-first-last">The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></div><div id="S6" class="tsec sec"><h2 class="head no_bottom_margin" id="S6title">Ethics statement</h2><p class="p p-first-last">The studies involving human participants were reviewed and approved by the Ethics Committee of Tampere University Hospital. The patients/participants provided their written informed consent to participate in this study.</p></div><div id="S7" class="tsec sec"><h2 class="head no_bottom_margin" id="S7title">Author contributions</h2><p class="p p-first-last">PB and MPel analyzed the data and wrote the manuscript with input from all authors. JR performed statistical analyses. JP, MPes, SL, and SR conceived the study design. JP and MPes supervised the research. All authors contributed to the article and approved the submitted version.</p></div><div id="S8" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="S8title">Conflict of interest</h2><!--/article/back/sec/--><p class="p p-first-last">MPes was employed by Fimlab Laboratories Ltd., and Gilead Sciences, Finland. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></div><div id="S9" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="S9title">Publisher&#x02019;s note</h2><!--/article/back/sec/--><p class="p p-first-last">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></div><div id="S10" class="tsec bk-sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="S10title">Supplementary material</h2><!--/article/back/sec/--><p class="p p-first">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fncel.2023.1129907/full#supplementary-material" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">https://www.frontiersin.org/articles/10.3389/fncel.2023.1129907/full#supplementary-material</a></p><div class="sec suppmat" id="DS1"><div class="sup-box half_rhythm" id="media-a.k.c.c.a"><a href="/pmc/articles/PMC10070787/bin/Data_Sheet_1.pdf" data-ga-action="click_feat_suppl">Click here for additional data file.</a><sup>(887K, pdf)</sup></div></div></div><div id="ref-list-a.k.d" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.k.dtitle">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="mixed-citation">Alapirtti T., Lehtimaki K., Nieminen R., Makinen R., Raitanen J., Moilanen E., et al. (2018). <span class="ref-title">The production of IL-6 in acute epileptic seizure: A video-EEG study.</span>
<span class="ref-journal"><em>J. Neuroimmunol.</em></span>
<span class="ref-vol">316</span>
50&#x02013;55. 10.1016/j.jneuroim.2017.12.008
 [<a href="https://pubmed.ncbi.nlm.nih.gov/29273305" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jneuroim.2017.12.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neuroimmunol.&amp;title=The+production+of+IL-6+in+acute+epileptic+seizure:+A+video-EEG+study.&amp;author=T.+Alapirtti&amp;author=K.+Lehtimaki&amp;author=R.+Nieminen&amp;author=R.+Makinen&amp;author=J.+Raitanen&amp;volume=316&amp;publication_year=2018&amp;pages=50-55&amp;pmid=29273305&amp;doi=10.1016/j.jneuroim.2017.12.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="mixed-citation">Alapirtti T., Rinta S., Hulkkonen J., Makinen R., Keranen T., Peltola J. (2009). <span class="ref-title">Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: A video-EEG study.</span>
<span class="ref-journal"><em>J. Neurol. Sci.</em></span>
<span class="ref-vol">280</span>
94&#x02013;97. 10.1016/j.jns.2009.02.355
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19272615" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jns.2009.02.355" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neurol.+Sci.&amp;title=Interleukin-6,+interleukin-1+receptor+antagonist+and+interleukin-1beta+production+in+patients+with+focal+epilepsy:+A+video-EEG+study.&amp;author=T.+Alapirtti&amp;author=S.+Rinta&amp;author=J.+Hulkkonen&amp;author=R.+Makinen&amp;author=T.+Keranen&amp;volume=280&amp;publication_year=2009&amp;pages=94-97&amp;pmid=19272615&amp;doi=10.1016/j.jns.2009.02.355&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="mixed-citation">Ali F., Rowley M., Jayakrishnan B., Teuber S., Gershwin M. E., Mackay I. R. (2011). <span class="ref-title">Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: Protean additions to the autoimmune central neuropathies.</span>
<span class="ref-journal"><em>J. Autoimmun.</em></span>
<span class="ref-vol">37</span>
79&#x02013;87. 10.1016/j.jaut.2011.05.005
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21680149" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jaut.2011.05.005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Autoimmun.&amp;title=Stiff-person+syndrome+(SPS)+and+anti-GAD-related+CNS+degenerations:+Protean+additions+to+the+autoimmune+central+neuropathies.&amp;author=F.+Ali&amp;author=M.+Rowley&amp;author=B.+Jayakrishnan&amp;author=S.+Teuber&amp;author=M.+E.+Gershwin&amp;volume=37&amp;publication_year=2011&amp;pages=79-87&amp;pmid=21680149&amp;doi=10.1016/j.jaut.2011.05.005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="mixed-citation">Amin K., Qadr S. H., Hassan Hussein R., Ali K. M., Rahman H. S. (2020). <span class="ref-title">Levels of cytokines and GADA in type I and II diabetic patients.</span>
<span class="ref-journal"><em>Prim. Care Diabetes</em></span>
<span class="ref-vol">14</span>
61&#x02013;67. 10.1016/j.pcd.2019.03.008
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31014937" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.pcd.2019.03.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prim.+Care+Diabetes&amp;title=Levels+of+cytokines+and+GADA+in+type+I+and+II+diabetic+patients.&amp;author=K.+Amin&amp;author=S.+H.+Qadr&amp;author=R.+Hassan+Hussein&amp;author=K.+M.+Ali&amp;author=H.+S.+Rahman&amp;volume=14&amp;publication_year=2020&amp;pages=61-67&amp;pmid=31014937&amp;doi=10.1016/j.pcd.2019.03.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="mixed-citation">Basnyat P., Basnyat P., Pesu M., Pesu M., S&#x000f6;derqvist M., Gr&#x000f6;nholm A., et al. (2020). <span class="ref-title">Chronically reduced IL-10 plasma levels are associated with hippocampal sclerosis in temporal lobe epilepsy patients.</span>
<span class="ref-journal"><em>BMC Neurol.</em></span>
<span class="ref-vol">20</span>:<span class="ref-iss">241</span>. 10.1186/s12883-020-01825-x
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7291453/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32532251" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12883-020-01825-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Neurol.&amp;title=Chronically+reduced+IL-10+plasma+levels+are+associated+with+hippocampal+sclerosis+in+temporal+lobe+epilepsy+patients.&amp;author=P.+Basnyat&amp;author=P.+Basnyat&amp;author=M.+Pesu&amp;author=M.+Pesu&amp;author=M.+S&#x000f6;derqvist&amp;volume=20&amp;issue=241&amp;publication_year=2020&amp;pmid=32532251&amp;doi=10.1186/s12883-020-01825-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="mixed-citation">Bien C. G., Scheffer I. E. (2011). <span class="ref-title">Autoantibodies and epilepsy.</span>
<span class="ref-journal"><em>Epilepsia</em></span>
<span class="ref-vol">52</span>(<span class="ref-iss">Suppl. 3</span>) 18&#x02013;22. 10.1111/j.1528-1167.2011.03031.x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/21542841" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1528-1167.2011.03031.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Autoantibodies+and+epilepsy.&amp;author=C.+G.+Bien&amp;author=I.+E.+Scheffer&amp;volume=52&amp;issue=Suppl.+3&amp;publication_year=2011&amp;pages=18-22&amp;pmid=21542841&amp;doi=10.1111/j.1528-1167.2011.03031.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="mixed-citation">Burton A. R., Baquet Z., Eisenbarth G. S., Tisch R., Smeyne R., Workman C. J., et al. (2010). <span class="ref-title">Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells.</span>
<span class="ref-journal"><em>J. Immunol.</em></span>
<span class="ref-vol">184</span>
4863&#x02013;4870. 10.4049/jimmunol.0903728
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2989406/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20348424" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.4049%2Fjimmunol.0903728" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Immunol.&amp;title=Central+nervous+system+destruction+mediated+by+glutamic+acid+decarboxylase-specific+CD4++T+cells.&amp;author=A.+R.+Burton&amp;author=Z.+Baquet&amp;author=G.+S.+Eisenbarth&amp;author=R.+Tisch&amp;author=R.+Smeyne&amp;volume=184&amp;publication_year=2010&amp;pages=4863-4870&amp;pmid=20348424&amp;doi=10.4049/jimmunol.0903728&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="mixed-citation">Chihara N., Aranami T., Sato W., Miyazaki Y., Miyake S., Okamoto T., et al. (2011). <span class="ref-title">Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.</span>
<span class="ref-journal"><em>Proc. Natl. Acad. Sci. U.S.A.</em></span>
<span class="ref-vol">108</span>
3701&#x02013;3706. 10.1073/pnas.1017385108
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3048150/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21321193" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1073%2Fpnas.1017385108" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A.&amp;title=Interleukin+6+signaling+promotes+anti-aquaporin+4+autoantibody+production+from+plasmablasts+in+neuromyelitis+optica.&amp;author=N.+Chihara&amp;author=T.+Aranami&amp;author=W.+Sato&amp;author=Y.+Miyazaki&amp;author=S.+Miyake&amp;volume=108&amp;publication_year=2011&amp;pages=3701-3706&amp;pmid=21321193&amp;doi=10.1073/pnas.1017385108&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="mixed-citation">Dafoulas G. E., Toulis K. A., Mccorry D., Kumarendran B., Thomas G. N., Willis B. H., et al. (2017). <span class="ref-title">Type 1 diabetes mellitus and risk of incident epilepsy: A population-based, open-cohort study.</span>
<span class="ref-journal"><em>Diabetologia</em></span>
<span class="ref-vol">60</span>
258&#x02013;261. 10.1007/s00125-016-4142-x
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6518067/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27796422" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00125-016-4142-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Type+1+diabetes+mellitus+and+risk+of+incident+epilepsy:+A+population-based,+open-cohort+study.&amp;author=G.+E.+Dafoulas&amp;author=K.+A.+Toulis&amp;author=D.+Mccorry&amp;author=B.+Kumarendran&amp;author=G.+N.+Thomas&amp;volume=60&amp;publication_year=2017&amp;pages=258-261&amp;pmid=27796422&amp;doi=10.1007/s00125-016-4142-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="mixed-citation">Falip M., Carre&#x000f1;o M., Mir&#x000f3; J., Saiz A., Villanueva V., Qu&#x000ed;lez A., et al. (2012). <span class="ref-title">Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.</span>
<span class="ref-journal"><em>Eur. J. Neurol.</em></span>
<span class="ref-vol">19</span>
827&#x02013;833. 10.1111/j.1468-1331.2011.03609.x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/22353320" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1468-1331.2011.03609.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Neurol.&amp;title=Prevalence+and+immunological+spectrum+of+temporal+lobe+epilepsy+with+glutamic+acid+decarboxylase+antibodies.&amp;author=M.+Falip&amp;author=M.+Carre&#x000f1;o&amp;author=J.+Mir&#x000f3;&amp;author=A.+Saiz&amp;author=V.+Villanueva&amp;volume=19&amp;publication_year=2012&amp;pages=827-833&amp;pmid=22353320&amp;doi=10.1111/j.1468-1331.2011.03609.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="mixed-citation">Kwan P., Arzimanoglou A., Berg A. T., Brodie M. J., Hauser W. A., Mathern G., et al. (2010). <span class="ref-title">Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies.</span>
<span class="ref-journal"><em>Epilepsia</em></span>
<span class="ref-vol">51</span>
1069&#x02013;1077. 10.1111/j.1528-1167.2009.02397.x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19889013" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1528-1167.2009.02397.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Definition+of+drug+resistant+epilepsy:+Consensus+proposal+by+the+ad+hoc+Task+Force+of+the+ILAE+commission+on+therapeutic+strategies.&amp;author=P.+Kwan&amp;author=A.+Arzimanoglou&amp;author=A.+T.+Berg&amp;author=M.+J.+Brodie&amp;author=W.+A.+Hauser&amp;volume=51&amp;publication_year=2010&amp;pages=1069-1077&amp;pmid=19889013&amp;doi=10.1111/j.1528-1167.2009.02397.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="mixed-citation">Liimatainen S., Fallah M., Kharazmi E., Peltola M., Peltola J. (2009). <span class="ref-title">Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy.</span>
<span class="ref-journal"><em>J. Neurol.</em></span>
<span class="ref-vol">256</span>
796&#x02013;802. 10.1007/s00415-009-5021-x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19252806" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00415-009-5021-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neurol.&amp;title=Interleukin-6+levels+are+increased+in+temporal+lobe+epilepsy+but+not+in+extra-temporal+lobe+epilepsy.&amp;author=S.+Liimatainen&amp;author=M.+Fallah&amp;author=E.+Kharazmi&amp;author=M.+Peltola&amp;author=J.+Peltola&amp;volume=256&amp;publication_year=2009&amp;pages=796-802&amp;pmid=19252806&amp;doi=10.1007/s00415-009-5021-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="mixed-citation">Liimatainen S., Lehtimaki K., Palmio J., Alapirtti T., Peltola J. (2013). <span class="ref-title">Immunological perspectives of temporal lobe seizures.</span>
<span class="ref-journal"><em>J. Neuroimmunol.</em></span>
<span class="ref-vol">263</span>
1&#x02013;7. 10.1016/j.jneuroim.2013.08.001
 [<a href="https://pubmed.ncbi.nlm.nih.gov/23998423" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jneuroim.2013.08.001" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neuroimmunol.&amp;title=Immunological+perspectives+of+temporal+lobe+seizures.&amp;author=S.+Liimatainen&amp;author=K.+Lehtimaki&amp;author=J.+Palmio&amp;author=T.+Alapirtti&amp;author=J.+Peltola&amp;volume=263&amp;publication_year=2013&amp;pages=1-7&amp;pmid=23998423&amp;doi=10.1016/j.jneuroim.2013.08.001&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="mixed-citation">Liimatainen S., Peltola J., Hietaharju A., Sabater L., Lang B. (2014). <span class="ref-title">Lack of antibodies to NMDAR or VGKC-complex in GAD and cardiolipin antibody-positive refractory epilepsy.</span>
<span class="ref-journal"><em>Epilepsy Res.</em></span>
<span class="ref-vol">108</span>
592&#x02013;596. 10.1016/j.eplepsyres.2013.12.015
 [<a href="https://pubmed.ncbi.nlm.nih.gov/24447612" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.eplepsyres.2013.12.015" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy+Res.&amp;title=Lack+of+antibodies+to+NMDAR+or+VGKC-complex+in+GAD+and+cardiolipin+antibody-positive+refractory+epilepsy.&amp;author=S.+Liimatainen&amp;author=J.+Peltola&amp;author=A.+Hietaharju&amp;author=L.+Sabater&amp;author=B.+Lang&amp;volume=108&amp;publication_year=2014&amp;pages=592-596&amp;pmid=24447612&amp;doi=10.1016/j.eplepsyres.2013.12.015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="mixed-citation">Liimatainen S., Peltola M., Sabater L., Fallah M., Kharazmi E., Haapala A. M., et al. (2010). <span class="ref-title">Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy.</span>
<span class="ref-journal"><em>Epilepsia</em></span>
<span class="ref-vol">51</span>
760&#x02013;767. 10.1111/j.1528-1167.2009.02325.x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/19817821" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fj.1528-1167.2009.02325.x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Clinical+significance+of+glutamic+acid+decarboxylase+antibodies+in+patients+with+epilepsy.&amp;author=S.+Liimatainen&amp;author=M.+Peltola&amp;author=L.+Sabater&amp;author=M.+Fallah&amp;author=E.+Kharazmi&amp;volume=51&amp;publication_year=2010&amp;pages=760-767&amp;pmid=19817821&amp;doi=10.1111/j.1528-1167.2009.02325.x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="mixed-citation">Lobo-Silva D., Carriche G. M., Castro A. G., Roque S., Saraiva M. (2016). <span class="ref-title">Balancing the immune response in the brain: IL-10 and its regulation.</span>
<span class="ref-journal"><em>J. Neuroinflammation</em></span>
<span class="ref-vol">13</span>
297&#x02013;298. 10.1186/s12974-016-0763-8
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5121946/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27881137" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2Fs12974-016-0763-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neuroinflammation&amp;title=Balancing+the+immune+response+in+the+brain:+IL-10+and+its+regulation.&amp;author=D.+Lobo-Silva&amp;author=G.+M.+Carriche&amp;author=A.+G.+Castro&amp;author=S.+Roque&amp;author=M.+Saraiva&amp;volume=13&amp;publication_year=2016&amp;pages=297-298&amp;pmid=27881137&amp;doi=10.1186/s12974-016-0763-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="mixed-citation">M&#x000e4;kel&#x000e4; K. M., Hietaharju A., Brander A., Peltola J. (2018). <span class="ref-title">Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: The interplay between immunotherapy and anti-epileptic drugs.</span>
<span class="ref-journal"><em>Front. Neurol.</em></span>
<span class="ref-vol">9</span>:<span class="ref-iss">579</span>. 10.3389/fneur.2018.00579
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6053535/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30057567" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3389%2Ffneur.2018.00579" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front.+Neurol.&amp;title=Clinical+management+of+epilepsy+with+glutamic+acid+decarboxylase+antibody+positivity:+The+interplay+between+immunotherapy+and+anti-epileptic+drugs.&amp;author=K.+M.+M&#x000e4;kel&#x000e4;&amp;author=A.+Hietaharju&amp;author=A.+Brander&amp;author=J.+Peltola&amp;volume=9&amp;issue=579&amp;publication_year=2018&amp;pmid=30057567&amp;doi=10.3389/fneur.2018.00579&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="mixed-citation">McKeon A., Robinson M. T., McEvoy K. M., Matsumoto J. Y., Lennon V. A., Ahlskog J. E., et al. (2012). <span class="ref-title">Stiff-man syndrome and variants: Clinical course, treatments, and outcomes.</span>
<span class="ref-journal"><em>Arch. Neurol.</em></span>
<span class="ref-vol">69</span>
230&#x02013;238. 10.1001/archneurol.2011.991
 [<a href="https://pubmed.ncbi.nlm.nih.gov/22332190" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1001%2Farchneurol.2011.991" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch.+Neurol.&amp;title=Stiff-man+syndrome+and+variants:+Clinical+course,+treatments,+and+outcomes.&amp;author=A.+McKeon&amp;author=M.+T.+Robinson&amp;author=K.+M.+McEvoy&amp;author=J.+Y.+Matsumoto&amp;author=V.+A.+Lennon&amp;volume=69&amp;publication_year=2012&amp;pages=230-238&amp;pmid=22332190&amp;doi=10.1001/archneurol.2011.991&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="mixed-citation">McKnight K., Jiang Y., Hart Y., Cavey A., Wroe S., Blank M., et al. (2005). <span class="ref-title">Serum antibodies in epilepsy and seizure-associated disorders.</span>
<span class="ref-journal"><em>Neurology</em></span>
<span class="ref-vol">65</span>
1730&#x02013;1736. 10.1212/01.wnl.0000187129.66353.13
 [<a href="https://pubmed.ncbi.nlm.nih.gov/16344514" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1212%2F01.wnl.0000187129.66353.13" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Serum+antibodies+in+epilepsy+and+seizure-associated+disorders.&amp;author=K.+McKnight&amp;author=Y.+Jiang&amp;author=Y.+Hart&amp;author=A.+Cavey&amp;author=S.+Wroe&amp;volume=65&amp;publication_year=2005&amp;pages=1730-1736&amp;pmid=16344514&amp;doi=10.1212/01.wnl.0000187129.66353.13&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="mixed-citation">Mitoma H., Song S. Y., Ishida K., Yamakuni T., Kobayashi T., Mizusawa H. (2000). <span class="ref-title">Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.</span>
<span class="ref-journal"><em>J. Neurol. Sci.</em></span>
<span class="ref-vol">175</span>
40&#x02013;44. 10.1016/S0022-510X(00)00272-0
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10785255" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0022-510X(00)00272-0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Neurol.+Sci.&amp;title=Presynaptic+impairment+of+cerebellar+inhibitory+synapses+by+an+autoantibody+to+glutamate+decarboxylase.&amp;author=H.+Mitoma&amp;author=S.+Y.+Song&amp;author=K.+Ishida&amp;author=T.+Yamakuni&amp;author=T.+Kobayashi&amp;volume=175&amp;publication_year=2000&amp;pages=40-44&amp;pmid=10785255&amp;doi=10.1016/S0022-510X(00)00272-0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="mixed-citation">Moudgil K. D., Choubey D. (2011). <span class="ref-title">Cytokines in autoimmunity: Role in induction, regulation, and treatment.</span>
<span class="ref-journal"><em>J. Interferon Cytokine Res.</em></span>
<span class="ref-vol">31</span>
695&#x02013;703. 10.1089/jir.2011.0065
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3189547/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21942420" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1089%2Fjir.2011.0065" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Interferon+Cytokine+Res.&amp;title=Cytokines+in+autoimmunity:+Role+in+induction,+regulation,+and+treatment.&amp;author=K.+D.+Moudgil&amp;author=D.+Choubey&amp;volume=31&amp;publication_year=2011&amp;pages=695-703&amp;pmid=21942420&amp;doi=10.1089/jir.2011.0065&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="mixed-citation">Munoz-Lopetegi A., de Bruijn M. A. A. M., Boukhrissi S., Bastiaansen A. E. M., Nagtzaam M. M. P., Hulsenboom E. S. P., et al. (2020). <span class="ref-title">Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.</span>
<span class="ref-journal"><em>Neurol. Neuroimmunol. Neuroinflamm.</em></span>
<span class="ref-vol">7</span>:<span class="ref-iss">e696</span>. 10.1212/NXI.0000000000000696
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7136051/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32123047" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1212%2FNXI.0000000000000696" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurol.+Neuroimmunol.+Neuroinflamm.&amp;title=Neurologic+syndromes+related+to+anti-GAD65:+Clinical+and+serologic+response+to+treatment.&amp;author=A.+Munoz-Lopetegi&amp;author=M.+A.+A.+M.+de+Bruijn&amp;author=S.+Boukhrissi&amp;author=A.+E.+M.+Bastiaansen&amp;author=M.+M.+P.+Nagtzaam&amp;volume=7&amp;issue=e696&amp;publication_year=2020&amp;pmid=32123047&amp;doi=10.1212/NXI.0000000000000696&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="mixed-citation">Ng W. Y., Thai A. C., Lui K. F., Yeo P. P. B., Cheah J. S. (1999). <span class="ref-title">Systemic levels of cytokines and GAD-specific autoantibodies isotypes in Chinese IDDM patients.</span>
<span class="ref-journal"><em>Diabetes Res. Clin. Pract.</em></span>
<span class="ref-vol">43</span>
127&#x02013;135. 10.1016/S0168-8227(98)00130-2
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10221665" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2FS0168-8227(98)00130-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Res.+Clin.+Pract.&amp;title=Systemic+levels+of+cytokines+and+GAD-specific+autoantibodies+isotypes+in+Chinese+IDDM+patients.&amp;author=W.+Y.+Ng&amp;author=A.+C.+Thai&amp;author=K.+F.+Lui&amp;author=P.+P.+B.+Yeo&amp;author=J.+S.+Cheah&amp;volume=43&amp;publication_year=1999&amp;pages=127-135&amp;pmid=10221665&amp;doi=10.1016/S0168-8227(98)00130-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="mixed-citation">Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., et al. (2000). <span class="ref-title">Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy.</span>
<span class="ref-journal"><em>Neurology</em></span>
<span class="ref-vol">55</span>
46&#x02013;50. 10.1212/WNL.55.1.46
 [<a href="https://pubmed.ncbi.nlm.nih.gov/10891904" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1212%2FWNL.55.1.46" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Autoantibodies+to+glutamic+acid+decarboxylase+in+patients+with+therapy-resistant+epilepsy.&amp;author=J.+Peltola&amp;author=P.+Kulmala&amp;author=J.+Isojarvi&amp;author=A.+Saiz&amp;author=K.+Latvala&amp;volume=55&amp;publication_year=2000&amp;pages=46-50&amp;pmid=10891904&amp;doi=10.1212/WNL.55.1.46&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="mixed-citation">Petroff O. A., Rothman D. L., Behar K. L., Mattson R. H. (1996). <span class="ref-title">Low brain GABA level is associated with poor seizure control.</span>
<span class="ref-journal"><em>Ann. Neurol.</em></span>
<span class="ref-vol">40</span>
908&#x02013;911. 10.1002/ana.410400613
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9007096" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1002%2Fana.410400613" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+Neurol.&amp;title=Low+brain+GABA+level+is+associated+with+poor+seizure+control.&amp;author=O.+A.+Petroff&amp;author=D.+L.+Rothman&amp;author=K.+L.+Behar&amp;author=R.+H.+Mattson&amp;volume=40&amp;publication_year=1996&amp;pages=908-911&amp;pmid=9007096&amp;doi=10.1002/ana.410400613&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B26"><span class="mixed-citation">Ranua J., Luoma K., Peltola J., Haapala A. M., Raitanen J., Auvinen A., et al. (2004). <span class="ref-title">Anticardiolipin and antinuclear antibodies in epilepsy&#x02013;a population-based cross-sectional study.</span>
<span class="ref-journal"><em>Epilepsy Res.</em></span>
<span class="ref-vol">58</span>
13&#x02013;18. 10.1016/j.eplepsyres.2003.12.004
 [<a href="https://pubmed.ncbi.nlm.nih.gov/15066670" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.eplepsyres.2003.12.004" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy+Res.&amp;title=Anticardiolipin+and+antinuclear+antibodies+in+epilepsy&#x02013;a+population-based+cross-sectional+study.&amp;author=J.+Ranua&amp;author=K.+Luoma&amp;author=J.+Peltola&amp;author=A.+M.+Haapala&amp;author=J.+Raitanen&amp;volume=58&amp;publication_year=2004&amp;pages=13-18&amp;pmid=15066670&amp;doi=10.1016/j.eplepsyres.2003.12.004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B27"><span class="mixed-citation">Savola K., Sabbah E., Kulmala P., Vahasalo P., Ilonen J., Knip M. (1998). <span class="ref-title">Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.</span>
<span class="ref-journal"><em>Diabetologia</em></span>
<span class="ref-vol">41</span>
1293&#x02013;1297. 10.1007/s001250051067
 [<a href="https://pubmed.ncbi.nlm.nih.gov/9833935" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs001250051067" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Autoantibodies+associated+with+Type+I+diabetes+mellitus+persist+after+diagnosis+in+children.&amp;author=K.+Savola&amp;author=E.+Sabbah&amp;author=P.+Kulmala&amp;author=P.+Vahasalo&amp;author=J.+Ilonen&amp;volume=41&amp;publication_year=1998&amp;pages=1293-1297&amp;pmid=9833935&amp;doi=10.1007/s001250051067&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B28"><span class="mixed-citation">Scheffer I. E., Berkovic S., Capovilla G., Connolly M. B., French J., Guilhoto L., et al. (2017). <span class="ref-title">ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.</span>
<span class="ref-journal"><em>Epilepsia</em></span>
<span class="ref-vol">58</span>
512&#x02013;521. 10.1111/epi.13709
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5386840/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28276062" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fepi.13709" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=ILAE+classification+of+the+epilepsies:+Position+paper+of+the+ILAE+Commission+for+Classification+and+Terminology.&amp;author=I.+E.+Scheffer&amp;author=S.+Berkovic&amp;author=G.+Capovilla&amp;author=M.+B.+Connolly&amp;author=J.+French&amp;volume=58&amp;publication_year=2017&amp;pages=512-521&amp;pmid=28276062&amp;doi=10.1111/epi.13709&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B29"><span class="mixed-citation">Siewko K., Maciulewski R., Zielinska-Maciulewska A., Poplawska-Kita A., Szumowski P., Wawrusiewicz-Kurylonek N., et al. (2019). <span class="ref-title">Interleukin-6 and interleukin-15 as possible biomarkers of the risk of autoimmune diabetes development.</span>
<span class="ref-journal"><em>Biomed. Res. Int.</em></span>
<span class="ref-vol">2019</span>:<span class="ref-iss">4734063</span>. 10.1155/2019/4734063
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6854156/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31772933" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1155%2F2019%2F4734063" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomed.+Res.+Int.&amp;title=Interleukin-6+and+interleukin-15+as+possible+biomarkers+of+the+risk+of+autoimmune+diabetes+development.&amp;author=K.+Siewko&amp;author=R.+Maciulewski&amp;author=A.+Zielinska-Maciulewska&amp;author=A.+Poplawska-Kita&amp;author=P.+Szumowski&amp;volume=2019&amp;issue=4734063&amp;publication_year=2019&amp;pmid=31772933&amp;doi=10.1155/2019/4734063&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B30"><span class="mixed-citation">Sigurdsson E., Baekkeskov S. (1990). <span class="ref-title">The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus.</span>
<span class="ref-journal"><em>Curr. Top. Microbiol. Immunol.</em></span>
<span class="ref-vol">164</span>
143&#x02013;168. 10.1007/978-3-642-75741-9_8
 [<a href="https://pubmed.ncbi.nlm.nih.gov/2073783" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2F978-3-642-75741-9_8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Top.+Microbiol.+Immunol.&amp;title=The+64-kDa+beta+cell+membrane+autoantigen+and+other+target+molecules+of+humoral+autoimmunity+in+insulin-dependent+diabetes+mellitus.&amp;author=E.+Sigurdsson&amp;author=S.+Baekkeskov&amp;volume=164&amp;publication_year=1990&amp;pages=143-168&amp;pmid=2073783&amp;doi=10.1007/978-3-642-75741-9_8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B31"><span class="mixed-citation">Solimena M., De Camilli P. (1991). <span class="ref-title">Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus.</span>
<span class="ref-journal"><em>Trends Neurosci.</em></span>
<span class="ref-vol">14</span>
452&#x02013;457. 10.1016/0166-2236(91)90044-U
 [<a href="https://pubmed.ncbi.nlm.nih.gov/1722364" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2F0166-2236(91)90044-U" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Neurosci.&amp;title=Autoimmunity+to+glutamic+acid+decarboxylase+(GAD)+in+Stiff-Man+syndrome+and+insulin-dependent+diabetes+mellitus.&amp;author=M.+Solimena&amp;author=P.+De+Camilli&amp;volume=14&amp;publication_year=1991&amp;pages=452-457&amp;pmid=1722364&amp;doi=10.1016/0166-2236(91)90044-U&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B32"><span class="mixed-citation">Toledano M., Britton J. W., McKeon A., Shin C., Lennon V. A., Quek A. M., et al. (2014). <span class="ref-title">Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy.</span>
<span class="ref-journal"><em>Neurology</em></span>
<span class="ref-vol">82</span>
1578&#x02013;1586. 10.1212/WNL.0000000000000383
 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4013813/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24706013" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1212%2FWNL.0000000000000383" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Utility+of+an+immunotherapy+trial+in+evaluating+patients+with+presumed+autoimmune+epilepsy.&amp;author=M.+Toledano&amp;author=J.+W.+Britton&amp;author=A.+McKeon&amp;author=C.+Shin&amp;author=V.+A.+Lennon&amp;volume=82&amp;publication_year=2014&amp;pages=1578-1586&amp;pmid=24706013&amp;doi=10.1212/WNL.0000000000000383&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B33"><span class="mixed-citation">Vezzani A., Balosso S., Ravizza T. (2019). <span class="ref-title">Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy.</span>
<span class="ref-journal"><em>Nat. Rev.</em></span>
<span class="ref-vol">15</span>
459&#x02013;472. 10.1038/s41582-019-0217-x
 [<a href="https://pubmed.ncbi.nlm.nih.gov/31263255" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41582-019-0217-x" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.&amp;title=Neuroinflammatory+pathways+as+treatment+targets+and+biomarkers+in+epilepsy.&amp;author=A.+Vezzani&amp;author=S.+Balosso&amp;author=T.+Ravizza&amp;volume=15&amp;publication_year=2019&amp;pages=459-472&amp;pmid=31263255&amp;doi=10.1038/s41582-019-0217-x&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B34"><span class="mixed-citation">Vianello M., Bisson G., Dal Maschio M., Vassanelli S., Girardi S., Mucignat C., et al. (2008). <span class="ref-title">Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies.</span>
<span class="ref-journal"><em>Autoimmunity</em></span>
<span class="ref-vol">41</span>
66&#x02013;73. 10.1080/08916930701619565
 [<a href="https://pubmed.ncbi.nlm.nih.gov/18176866" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F08916930701619565" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Autoimmunity&amp;title=Increased+spontaneous+activity+of+a+network+of+hippocampal+neurons+in+culture+caused+by+suppression+of+inhibitory+potentials+mediated+by+anti-gad+antibodies.&amp;author=M.+Vianello&amp;author=G.+Bisson&amp;author=M.+Dal+Maschio&amp;author=S.+Vassanelli&amp;author=S.+Girardi&amp;volume=41&amp;publication_year=2008&amp;pages=66-73&amp;pmid=18176866&amp;doi=10.1080/08916930701619565&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B35"><span class="mixed-citation">Yan D., Zhao E., Zhang H., Luo X., Du Y. (2017). <span class="ref-title">Association between type 1 diabetes mellitus and risk of epilepsy: A meta-analysis of observational studies.</span>
<span class="ref-journal"><em>Drug Discov. Ther.</em></span>
<span class="ref-vol">11</span>
146&#x02013;151. 10.5582/ddt.2017.01020
 [<a href="https://pubmed.ncbi.nlm.nih.gov/28757515" ref="reftype=pubmed&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5582%2Fddt.2017.01020" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Discov.+Ther.&amp;title=Association+between+type+1+diabetes+mellitus+and+risk+of+epilepsy:+A+meta-analysis+of+observational+studies.&amp;author=D.+Yan&amp;author=E.+Zhao&amp;author=H.+Zhang&amp;author=X.+Luo&amp;author=Y.+Du&amp;volume=11&amp;publication_year=2017&amp;pages=146-151&amp;pmid=28757515&amp;doi=10.5582/ddt.2017.01020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=10070787&amp;issue-id=427476&amp;journal-id=639&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Frontiers in Cellular Neuroscience</span> are provided here courtesy of <strong>Frontiers Media SA</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC10070787/pdf/fncel-17-1129907.pdf" class="int-view">PDF (1.1M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/10070787/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/10070787/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="10070787" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="ToX0vkpyA0pCDDMD9G51p4hdwMJceCidU6PZU4eHxGN2rfuBcx18T3d774F95mYc">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F&amp;text=Elevated%20IL-6%20plasma%20levels%20are%20associated%20with%20GAD%20antibodies-associated%20autoimmune%20epilepsy" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10070787%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070787/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/37025699/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/37025699/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC10070787/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/10070787/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC10070787/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
